The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

[1]  C. Shi,et al.  Tumor Necrosis Factor (TNF)-induced Germinal Center Kinase-related (GCKR) and Stress-activated Protein Kinase (SAPK) Activation Depends upon the E2/E3 Complex Ubc13-Uev1A/TNF Receptor-associated Factor 2 (TRAF2)* , 2003, The Journal of Biological Chemistry.

[2]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[3]  Inder M. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[4]  David Baltimore,et al.  Two Pathways to NF-κB , 2002 .

[5]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[6]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[7]  Michael T. McManus,et al.  Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.

[8]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[9]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[10]  Young Chul Park,et al.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. , 2002, Journal of cell science.

[11]  Francesca Zazzeroni,et al.  Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.

[12]  A. Smahi,et al.  NEMO/IKK?: linking NF-?B to human disease , 2001 .

[13]  J. Pober,et al.  Tumor necrosis factor receptor-associated factors (TRAFs) , 2001, Oncogene.

[14]  W. Birchmeier,et al.  Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. , 2001, Development.

[15]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[16]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[17]  A. Fischer,et al.  X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling , 2001, Nature Genetics.

[18]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[19]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[20]  A. Israël.  The IKK complex: an integrator of all signals that activate NF-κB? , 2000 .

[21]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[22]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[23]  S. H. Baek,et al.  Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.

[24]  E. Kieff,et al.  The structural basis for the recognition of diverse receptor sequences by TRAF2. , 1999, Molecular cell.

[25]  T. Maniatis,et al.  A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.

[26]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[27]  D. Ballard,et al.  The Tax Oncoprotein of Human T-cell Leukemia Virus Type 1 Associates with and Persistently Activates IκB Kinases Containing IKKα and IKKβ* , 1998, The Journal of Biological Chemistry.

[28]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[29]  D. Pellman,et al.  Deubiquitinating enzymes: a new class of biological regulators. , 1998, Critical reviews in biochemistry and molecular biology.

[30]  K. Wilkinson.  Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[32]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[33]  A. Israël,et al.  NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.

[34]  R. Hennekam,et al.  Dermal eccrine cylindromatosis. , 1994, Journal of medical genetics.

[35]  T. Nakamura,et al.  Molecular cloning of a novel oncogene generated by DNA recombination during transfection. , 1988, Oncogene research.

[36]  H. Holtmann,et al.  Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. , 1988, Immunobiology.